-
Published16/05/2025
-
Deadline18/06/2025
-
Opening of tenders18/06/2025
-
Today23/06/2025
Utilities
- indicates text translated automatically in your browsing language
FRAMEWORK SUPPLY AGREEMENT - Miscellaneous medicinal products for human use 2025-2026 Text automatically translated in your browsing language Automatically translated
The medicinal products tendered must be included in the updated Nomenclature of medicinal products for human use (www.anm.ro) according to Order 4858/C/3363/2022 MJ-MS. Each medicinal product tendered must hold a marketing authorisation issued by the ANMDMR in accordance with Article 704 of Law No 95/2006***Republished, valid for the entire duration of the contract. Taking into account the fact that we have the obligation to ensure uninterrupted medical treatment for the number of detainees, in conjunction with the need to estimate updated prices for the quarterly budget, I propose for approval the approach of the open tender procedure with the conclusion of a framework agreement’, in accordance with Article 7(1)(b) of Law 98/2016, in conjunction with Article 74(4) of Law No 98/2016, as amended, with repetitive delivery of medicinal products on a monthly, two-month or quarterly basis, depending on the budget allocation and the fluctuation of staff. The need was established on the basis of the requests submitted from the sections and the assigned penitentiaries, the existing pathology and the consumption from the previous years. Text automatically translated in your browsing language Automatically translated
https://www.e-licitatie.ro
https://www.e-licitatie.ro
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.